Stay updated on INOXT for ASD Clinical Trial
Sign up to get notified when there's something new on the INOXT for ASD Clinical Trial page.

Latest updates to the INOXT for ASD Clinical Trial page
- Check7 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for a completed Phase 2 study of intranasal oxytocin for adults with autism spectrum disorder. It includes the study design, eligibility criteria, locations, investigators, and outcome measures.SummaryDifference44%

- Check14 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedA notice about NIH’s terminology transition appears above the site navigation, and the site revision advances from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 Forbidden page. The error content and layout remain unchanged.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating restricted access to the ClinicalTrials.gov record. It replaces the expected content with an error page.SummaryDifference17%

- Check63 days agoChange DetectedThe page shows a revision label updated from v3.6.6 to v3.7.0, signaling a newer version of the page template. This reflects an interface/backend update rather than changes to the study information itself.SummaryDifference0.1%

Stay in the know with updates to INOXT for ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INOXT for ASD Clinical Trial page.